Novartis Advances Cosentyx for Polymyalgia Rheumatica
Basel, Switzerland, September 18, 2026 Novartis has announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
CHMP
Advertisement
MaaT Pharma Advances PHOENIX After Negative EMA Opinion
LYON, France — September 18, 2026 MaaT Pharma announced that the Committee for Medicinal Products for Human Use (CHMP)...
Novo Nordisk Gains Positive CHMP Opinion for FREHEMGO
BAGSVAERD, Denmark — September 17, 2026 Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP)...
LEO Pharma Gains Positive CHMP Opinion for Anzupgo
BALLERUP, Denmark — September 18, 2026 LEO Pharma announced that the European Medicines Agency’s Committee for Medicinal Products for...
Johnson & Johnson TECVAYLI Gains Positive CHMP Opinion
Raritan, New Jersey, U.S., September 18, 2026 Johnson & Johnson has announced that the European Medicines Agency’s Committee for...
Advertisements
Astellas PADCEV and Keytruda Gain Positive CHMP Opinion
Tokyo, Japan, September 17, 2026 Astellas Pharma Inc. has announced that the European Medicines Agency’s Committee for Medicinal Products...
Teva Bids for BioXcel’s BXCL501 in Potential At-Home Agitation Treatment Deal
Tel Aviv, Israel – August 28, 2026 Teva Pharmaceutical Industries announced that it has entered into an agreement to...
Zambon Announces European Commission Approval of Hopledo for Parkinson’s Disease Motor Fluctuations
Milan, Italy – August 28, 2026 Zambon announced that the European Commission has granted marketing authorization for Hopledo® (modified-release...
Scholar Rock Advances Apitegromab FDA Review with Second Fill-Finish Facility
CAMBRIDGE, Mass., August 7, 2026 Scholar Rock announced that the U.S. Food and Drug Administration (FDA) review of its...
Cytokinetics Wins UK Approval for MYQORZO in oHCM
SOUTH SAN FRANCISCO, Calif., July 30, 2026 Cytokinetics, Incorporated has achieved a major regulatory and market access milestone for...
Advertisement
